Mid Size Pharmaceutical Market Scope And Analysis

  • Report Code : TIPRE00018321
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Mid-Size Pharmaceutical Market Analysis and Growth - 2031

Buy Now

Mid-Size Pharmaceutical Market Report Mid-Size Pharmaceutical Market Size and Share Mid-Size Pharmaceutical Market Scope and Analysis

Mid-Size Pharmaceutical Market Report Scope

Report Attribute Details
Market size in 2023 US$ 732.02 Billion
Market Size by 2031 US$ 1,224.039 Billion
Global CAGR (2023 - 2031) 8.9%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Prescription
  • Over the Counter
By Drug Development Type
  • in-house and outsource
By Formulation
  • tablets & capsules
  • injectables
  • sprays
  • other formulations
By Therapy Class
  • Cardiovascular Diseases
  • Pain Management
  • Diabetes
  • Cancer
  • Other Conditions
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • DAIICHI SANKYO COMPANY LIMITED
  • Eisai Co Ltd
  • Regeneron Pharmaceuticals Inc
  • Bausch Health Companies Inc
  • Sun Pharmaceutical Industries Ltd
  • Alexion Pharmaceuticals Inc
  • Mallinckrodt
  • Endo Pharmaceuticals Inc
  • Les Laboratories Servier
  • UCB S A